CTX — Crescita Therapeutics Share News
0.000.00%
Last trade - 00:00- CA$14.71m
- CA$8.50m
- CA$21.12m
Brief: Crescita Signs Exclusive 8-Country Licensing Agreement With Egis Pharmaceuticals For Pliaglis
Brief: Crescita Announces Exclusive Canadian Distribution Agreement With Obagi Cosmeceuticals Llc
Brief: Crescita Reports Q2 Results
Brief: Crescita Therapeutics Announces 9-Country Licensing Agreement With Croma Pharma For Pliaglis
Brief: Crescita Reports Qtrly Loss Per Share C$0.02
Crescita Therapeutics Inc: Falls on drop in quarterly revenue
Brief: Crescita Announces Filing Of New Medical Device License
Brief: Crescita Therapeutics Announces Approval Of Normal Course Issuer Bid
Brief: Crescita Therapeutics Inc Reports Quarterly Earnings Per Share 19 Cents
Brief: Crescita Reports Third Quarter 2020 Results
Brief: Crescita Announces Licensing Agreement For Pliaglis In China
Brief: Crescita Therapeutics Inc QTRLY Loss Per Share 15 Cents
Brief: Crescita To Receive One-Time Cash Payment Following Amendment To Pliaglis U.S. Licensing Agreement
Brief: Crescita To Receive One-Time Cash Payment Following Amendment To Pliaglis U.S. Licensing Agreement
Brief: Crescita Reports Q1 Loss Per Share $0.02
Brief: Crescita Therapeutics Announces Extension Of Q1 2020 Filings Due To Covid-19
Brief: Crescita Therapeutics Announces Measures In Response To Covid-19 Virus
Brief: Crescita Announces Positive Results From Late-Stage Studies For Plaque Psoriasis Therapy
Brief: Crescita Says Awarded Cannabis Research License From Health Canada